These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34975266)

  • 41. Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants.
    Chakraborty C; Sharma AR; Bhattacharya M; Agoramoorthy G; Lee SS
    mBio; 2021 Aug; 12(4):e0114021. PubMed ID: 34465019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RT-qPCR Assays for Rapid Detection of the N501Y, 69-70del, K417N, and E484K SARS-CoV-2 Mutations: A Screening Strategy to Identify Variants With Clinical Impact.
    Vega-Magaña N; Sánchez-Sánchez R; Hernández-Bello J; Venancio-Landeros AA; Peña-Rodríguez M; Vega-Zepeda RA; Galindo-Ornelas B; Díaz-Sánchez M; García-Chagollán M; Macedo-Ojeda G; García-González OP; Muñoz-Valle JF
    Front Cell Infect Microbiol; 2021; 11():672562. PubMed ID: 34123874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Genomics and epidemiology of SARS-CoV-2 lineage].
    Sukegawa S; Takeuchi H
    Uirusu; 2021; 71(1):19-32. PubMed ID: 35526991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In silico investigations of heparin binding to SARS-CoV-2 variants with a focus at the RBD/ACE2 interface.
    Ali N; Khan R; AlAsmari AF; Kumar V
    Process Biochem; 2022 Apr; 115():70-79. PubMed ID: 35194375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Whole-Genome Sequencing and Mutation Analyses of SARS-CoV-2 Isolates from Indonesia.
    Oktavianthi S; Lages AC; Kusuma R; Kurniasih TS; Trimarsanto H; Andriani F; Rustandi D; Meriyanti T; Yusuf I; Malik SG; Jo J; Suriapranata I
    Pathogens; 2024 Mar; 13(4):. PubMed ID: 38668234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity.
    Bhattacharya M; Chatterjee S; Sharma AR; Agoramoorthy G; Chakraborty C
    Appl Microbiol Biotechnol; 2021 Dec; 105(24):9035-9045. PubMed ID: 34755213
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations.
    Chakraborty C; Sharma AR; Bhattacharya M; Lee SS
    Front Immunol; 2022; 13():801522. PubMed ID: 35222380
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional Antibodies Against SARS-CoV-2 Receptor Binding Domain Variants with Mutations N501Y or E484K in Human Milk from COVID-19-Vaccinated, -Recovered, and -Unvaccinated Women.
    Demers-Mathieu V; Hakansson AP; Hall S; Lavangnananda S; Fels S; Medo E
    Breastfeed Med; 2022 Feb; 17(2):163-172. PubMed ID: 34809492
    [No Abstract]   [Full Text] [Related]  

  • 49. Infectivity and antigenicity of pseudoviruses with high-frequency mutations of SARS-CoV-2 identified in Portugal.
    Wang HX; Zhang L; Liang ZT; Nie JH; Wu JJ; Li QQ; Ding RX; Zhang Y; Chen GQ; Wang YC; Wang HG; Huang WJ
    Arch Virol; 2022 Feb; 167(2):459-470. PubMed ID: 35083576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-range enhancement of N501Y-endowed mouse infectivity of SARS-CoV-2 by the non-RBD mutations of Ins215KLRS and H655Y.
    Zhu Y; Zhou W; Niu Z; Sun J; Zhang Z; Li Q; Zheng Y; Wang C; Gao L; Sun Q
    Biol Direct; 2022 Jun; 17(1):14. PubMed ID: 35658928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.
    Motozono C; Toyoda M; Zahradnik J; Saito A; Nasser H; Tan TS; Ngare I; Kimura I; Uriu K; Kosugi Y; Yue Y; Shimizu R; Ito J; Torii S; Yonekawa A; Shimono N; Nagasaki Y; Minami R; Toya T; Sekiya N; Fukuhara T; Matsuura Y; Schreiber G; ; Ikeda T; Nakagawa S; Ueno T; Sato K
    Cell Host Microbe; 2021 Jul; 29(7):1124-1136.e11. PubMed ID: 34171266
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift.
    Li T; Cui Z; Jia Y; Liang Z; Nie J; Zhang L; Wang M; Li Q; Wu J; Xu N; Liu S; Li X; An Y; Han P; Zhang M; Li Y; Qu X; Wang Q; Huang W; Wang Y
    J Med Virol; 2022 May; 94(5):2108-2125. PubMed ID: 35032057
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera.
    Xie X; Liu Y; Liu J; Zhang X; Zou J; Fontes-Garfias CR; Xia H; Swanson KA; Cutler M; Cooper D; Menachery VD; Weaver SC; Dormitzer PR; Shi PY
    Nat Med; 2021 Apr; 27(4):620-621. PubMed ID: 33558724
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
    Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
    Front Immunol; 2021; 12():691715. PubMed ID: 34149735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern.
    Shahhosseini N; Babuadze GG; Wong G; Kobinger GP
    Microorganisms; 2021 Apr; 9(5):. PubMed ID: 33925854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike Mutations.
    Cocherie T; Zafilaza K; Leducq V; Marot S; Calvez V; Marcelin AG; Todesco E
    Microorganisms; 2022 Dec; 11(1):. PubMed ID: 36677322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The SARS-CoV-2 spike L452R-E484Q variant in the Indian B.1.617 strain showed significant reduction in the neutralization activity of immune sera.
    Li G; Zhou Z; Du P; Yu M; Li N; Xiong X; Huang H; Liu Z; Dai Q; Zhu J; Guo C; Wu S; Baptista-Hon DT; Miao M; Ming LW; Wu Y; Zeng F; Zhang CL; Zhang ED; Song H; Liu J; Lau JY; Xiang AP; Zhang K
    Precis Clin Med; 2021 Sep; 4(3):149-154. PubMed ID: 35693215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Research progress in spike mutations of SARS-CoV-2 variants and vaccine development.
    He X; He C; Hong W; Yang J; Wei X
    Med Res Rev; 2023 Jul; 43(4):932-971. PubMed ID: 36929527
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Key mutations on spike protein altering ACE2 receptor utilization and potentially expanding host range of emerging SARS-CoV-2 variants.
    Wang Q; Ye SB; Zhou ZJ; Li JY; Lv JZ; Hu B; Yuan S; Qiu Y; Ge XY
    J Med Virol; 2023 Jan; 95(1):e28116. PubMed ID: 36056469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes within the P681 residue of spike dictate cell fusion and syncytia formation of Delta and Omicron variants of SARS-CoV-2 with no effects on neutralization or infectivity.
    Kuzmina A; Korovin D; Cohen Lass I; Atari N; Ottolenghi A; Hu P; Mandelboim M; Rosental B; Rosenberg E; Diaz-Griffero F; Taube R
    Heliyon; 2023 Jun; 9(6):e16750. PubMed ID: 37292300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.